Janssen Pharmaceuticals Inc. v. A.Y.
Certiorari Denied
Petition for certiorari denied on May 17, 2021.
Docket No.20-1069
Op. BelowPa. Super. Ct.
Issue
Whether federal law preempts state-law claims that a manufacturer failed to provide adequate warnings relating to the off-label use of their products, where federal law bars the manufacturer from unilaterally altering its labeling to provide such warnings.
Jan 29, 2021Petition for a writ of certiorari filed. (Response due March 8, 2021)Feb 11, 2021Motion to extend the time to file a response from March 8, 2021 to April 7, 2021, submitted to The Clerk.
Feb 12, 2021Motion to extend the time to file a response is granted and the time is extended to and including April 7, 2021.
Mar 4, 2021Brief amicus curiae of Product Liability Advisory Council, Inc. filed.Mar 5, 2021Brief amicus curiae of Washington Legal Foundation filed.Mar 8, 2021Brief amici curiae of Pharmaceutical Research and Manufacturers of America, Chamber of Commerce of the United States of America, and American Tort Reform Association filed.Mar 8, 2021Brief amici curiae of National Association of Manufacturers and International Association of Defense Counsel filed.Apr 7, 2021Brief of respondents A.Y. and Billy Ann Yount in opposition filed.Apr 21, 2021DISTRIBUTED for Conference of 5/13/2021.
Apr 21, 2021Reply of petitioners Janssen Pharmaceuticals, Inc., et al. filed. (Distributed)May 17, 2021Petition DENIED. Justice Alito took no part in the consideration or decision of this petition.
Recommended Citation: Janssen Pharmaceuticals Inc. v. A.Y., SCOTUSblog, https://www.scotusblog.com/cases/janssen-pharmaceuticals-inc-v-a-y/